X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
female (22) 22
respiratory system (22) 22
male (21) 21
middle aged (21) 21
index medicus (19) 19
adult (15) 15
cardiac & cardiovascular systems (15) 15
pulmonary arterial hypertension (13) 13
pulmonary hypertension (13) 13
retrospective studies (13) 13
transplantation (12) 12
lung transplantation (11) 11
critical care medicine (10) 10
lung transplantation - adverse effects (10) 10
aged (9) 9
surgery (9) 9
therapy (9) 9
bronchiolitis obliterans - etiology (8) 8
care and treatment (8) 8
analysis (7) 7
cohort studies (7) 7
diagnosis (7) 7
hypertension, pulmonary - drug therapy (7) 7
risk factors (7) 7
risk-factors (7) 7
survival (7) 7
treprostinil (7) 7
abridged index medicus (6) 6
bronchiolitis-obliterans-syndrome (6) 6
drug therapy (6) 6
pulmonary/respiratory (6) 6
recipients (6) 6
survival analysis (6) 6
antihypertensive agents - therapeutic use (5) 5
article (5) 5
bronchiolitis obliterans syndrome (5) 5
chronic rejection (5) 5
clinical trials (5) 5
double-blind (5) 5
follow-up studies (5) 5
hemodynamics (5) 5
hereditary hemorrhagic telangiectasia (5) 5
hypertension, pulmonary - physiopathology (5) 5
severity of illness index (5) 5
time factors (5) 5
treatment outcome (5) 5
adolescent (4) 4
arterial-hypertension (4) 4
bronchoscopy (4) 4
disease (4) 4
dosage and administration (4) 4
dose-response relationship, drug (4) 4
endothelin receptor antagonist (4) 4
epoprostenol (4) 4
epoprostenol - analogs & derivatives (4) 4
graft rejection (4) 4
heart (4) 4
hemorrhage (4) 4
management (4) 4
patients (4) 4
peripheral vascular disease (4) 4
proportional hazards models (4) 4
sildenafil (4) 4
transplantation of organs, tissues, etc (4) 4
young adult (4) 4
acute disease (3) 3
allografts (3) 3
aortic valve stenosis (3) 3
bronchiolitis obliterans - mortality (3) 3
cardiology (3) 3
child (3) 3
complications (3) 3
disease progression (3) 3
epoprostenol - administration & dosage (3) 3
graft rejection - diagnosis (3) 3
graft rejection - etiology (3) 3
graft rejection - pathology (3) 3
hypertension (3) 3
hypertension, pulmonary - diagnosis (3) 3
hypertension, pulmonary - therapy (3) 3
immunology (3) 3
immunosuppressive agents - adverse effects (3) 3
infections (3) 3
lung transplantation - immunology (3) 3
medical colleges (3) 3
multivariate analysis (3) 3
mutation (3) 3
prognosis (3) 3
prospective studies (3) 3
prostacyclin (3) 3
quality-of-life (3) 3
rejection (3) 3
risk (3) 3
telangiectasia, hereditary hemorrhagic (3) 3
telangiectasia, hereditary hemorrhagic - complications (3) 3
telangiectasia, hereditary hemorrhagic - genetics (3) 3
telangiectasis (3) 3
vascular resistance - drug effects (3) 3
activin receptors, type ii - genetics (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiology Clinics, ISSN 0733-8651, 08/2016, Volume 34, Issue 3, pp. 489 - 500
Pulmonary hypertension remains a challenging condition to diagnose and manage. Decentralized care for pulmonary arterial hypertension (PAH) has led to... 
Comanagement | Accreditation | Pulmonary Hypertension Care Centers | Multidisciplinary care | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | REVEAL REGISTRY | ARTERIAL-HYPERTENSION | OUTCOMES | Cardiac Care Facilities | Disease Management | Guideline Adherence | Humans | Hypertension, Pulmonary - therapy
Journal Article
Journal Article
RESPIRATORY RESEARCH, ISSN 1465-993X, 09/2019, Volume 20, Issue 1, pp. 208 - 10
Background Initial combination therapy with ambrisentan and tadalafil reduced the risk of clinical failure events for treatment-naive participants with... 
DOUBLE-BLIND | SELEXIPAG | Combination therapy | RESPIRATORY SYSTEM | Research-clinical | Pulmonary hypertension | Hypertension | Confidence intervals | Therapy | Clinical trials | Risk analysis | Patients | Subgroups | Research
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2016, Volume 36, Issue 2, pp. 193 - 201
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2010, Volume 29, Issue 5, pp. 531 - 537
Journal Article
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 09/2019, Volume 291, pp. 127 - 133
Adults presenting with an unrepaired atrial septal defect and pulmonary arterial hypertension (ASD-PAH) are typically classified as “correctable” or... 
Atrial septal defect | Pulmonary arterial hypertension | Non-correctable | Treat-to-close | Non-repairable
Journal Article
Chest, ISSN 0012-3692, 07/2016, Volume 150, Issue 1, pp. 27 - 34
Journal Article
Circulation, ISSN 0009-7322, 05/2012, Volume 125, Issue 19, pp. 2353 - 2362
Background-Pressure overload resulting from aortic stenosis causes maladaptive ventricular and vascular remodeling that can lead to pulmonary hypertension,... 
aortic valve stenosis | hypertension, pulmonary | heart failure | hemodynamics | phosphodiesterase inhibitors | MORTALITY | EUROPEAN-ASSOCIATION | CARDIAC & CARDIOVASCULAR SYSTEMS | SILDENAFIL | DIASTOLIC FUNCTION | VALVE-REPLACEMENT | PERIPHERAL VASCULAR DISEASE | INDEX | HYPERTENSION | AMERICAN-SOCIETY | SYSTOLIC HEART-FAILURE | DOPPLER-ECHOCARDIOGRAPHY | Piperazines - administration & dosage | Aortic Valve Stenosis - drug therapy | Phosphodiesterase 5 Inhibitors - adverse effects | Humans | Sulfones - adverse effects | Male | Purines - administration & dosage | Aortic Valve Stenosis - diagnostic imaging | Sildenafil Citrate | Compliance - drug effects | Ultrasonography | Aged, 80 and over | Vascular Resistance - drug effects | Female | Blood Pressure - drug effects | Purines - adverse effects | Ventricular Function, Right - drug effects | Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism | Severity of Illness Index | Ventricular Function, Left - drug effects | Aortic Valve Stenosis - physiopathology | Phosphodiesterase 5 Inhibitors - administration & dosage | Stroke Volume - drug effects | Treatment Outcome | Piperazines - adverse effects | Aged | Pulmonary Circulation - drug effects | Sulfones - administration & dosage | Hypertension | Care and treatment | Aortic valve stenosis | Causes of | Patients | Pulmonary hypertension | Risk factors | Methods | phosphodiesterase type 5 inhibitors | pulmonary hypertension
Journal Article
INTERNATIONAL JOURNAL OF CARDIOLOGY, ISSN 0167-5273, 09/2019, Volume 291, pp. 127 - 133
Background: Adults presenting with an unrepaired atrial septal defect and pulmonary arterial hypertension (ASD-PAH) are typically classified as "correctable"... 
SURGICAL CLOSURE | SURVIVAL | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | PULMONARY ARTERIAL-HYPERTENSION | Non-repairable | GUIDELINES | ATRIAL SEPTAL-DEFECTS | ARRHYTHMIA | Non-correctable | Treat-to-close | THERAPY | CONGENITAL HEART-DISEASE | Atrial septal defect | Pulmonary arterial hypertension | Adults | Pulmonary hypertension | Genetic disorders
Journal Article
Journal Article
Chest, ISSN 0012-3692, 12/2017, Volume 152, Issue 6, pp. 1128 - 1134
Journal Article